| ACTH | Adrenocorticotropic hormone |
| ART | Assisted reproductive technologies |
| CRH | Corticotropin-releasing hormone |
| DHEAS | Dehydroepiandrosterone sulfate |
| DXA | Dual-energy X-ray absorptiometry |
| FSH | Follicle-stimulating hormone |
| GABA | Gamma-aminobutyric acid |
| GnRH | Gonadotropin-releasing hormone |
| HPA | Hypothalamic–pituitary–adrenal |
| HPG | Hypothalamic–pituitary–gonadal |
| HPT | Hypothalamic–pituitary–thyroid |
| HRT | Hormone replacement therapy |
| KNDy | Kisspeptin/neurokinin B/dynorphin |
| LARC | Long-acting reversible contraceptive |
| LH | Luteinizing hormone |
| MME | Morphine milligram equivalents |
| MOUD | Medications for opioid use disorder |
| NOWS | Neonatal opioid withdrawal syndrome |
| OIAI | Opioid-induced adrenal insufficiency |
| OUD | Opioid use disorder |
| PET | Positron emission tomography |
| PVN | Paraventricular nucleus |
| SOGC | Society of Obstetricians and Gynaecologists of Canada |
| T4 | Thyroxine |
| TRH | Thyrotropin-releasing hormone |
| TSH | Thyroid-stimulating hormone |
| VTE | Venous thromboembolism |